Certified by Founder Lodge
Maxion Therapeutics
United Kingdom - Cambridge
START UP
1 Disclosed Funding Rounds $16,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 21 ,2023 | Series A | $16,000,000 |
BGF
LifeArc Ventures
Monograph Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
